zanaflex

Generic: tizanidine hydrochloride

Labeler: trifluent pharma, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name zanaflex
Generic Name tizanidine hydrochloride
Labeler trifluent pharma, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 8 mg/1

Manufacturer
Trifluent Pharma, LLC

Identifiers & Regulatory

Product NDC 73352-090
Product ID 73352-090_4007fbf6-8eb7-85e9-e063-6394a90a4013
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213798
Listing Expiration 2026-12-31
Marketing Start 2025-09-16

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73352090
Hyphenated Format 73352-090

Supplemental Identifiers

RxCUI
2723708 2723710
UPC
0373352090600
UNII
B53E3NMY5C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zanaflex (source: ndc)
Generic Name tizanidine hydrochloride (source: ndc)
Application Number ANDA213798 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 8 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (73352-090-60)
source: ndc

Packages (1)

Ingredients (1)

tizanidine hydrochloride (8 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4007fbf6-8eb7-85e9-e063-6394a90a4013", "openfda": {"upc": ["0373352090600"], "unii": ["B53E3NMY5C"], "rxcui": ["2723708", "2723710"], "spl_set_id": ["9833a1b8-f530-4a06-bc77-7d11b6e94c65"], "manufacturer_name": ["Trifluent Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (73352-090-60)", "package_ndc": "73352-090-60", "marketing_start_date": "20250916"}], "brand_name": "Zanaflex", "product_id": "73352-090_4007fbf6-8eb7-85e9-e063-6394a90a4013", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "73352-090", "generic_name": "tizanidine hydrochloride", "labeler_name": "Trifluent Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zanaflex", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA213798", "marketing_category": "ANDA", "marketing_start_date": "20250916", "listing_expiration_date": "20261231"}